| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Finasteride | FAERS: 11 | US FAERS | |
| 2 | Sildenafil Citrate | FAERS: 4 | US FAERS | |
| 3 | Alprostadil | FAERS: 2 | OFFSIDES US FAERS | |
| 4 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 5 | Tadalafil | FAERS: 2 | US FAERS | |
| 6 | Tolterodine Tartrate | FAERS: 2 | US FAERS | |
| 7 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 8 | Leuprolide | FAERS: 1 | US FAERS | |
| 9 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 10 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 11 | Fluvastatin | OFFSIDES | ||
| 12 | Mycophenolic Acid | OFFSIDES | ||
| 13 | tianeptine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.